Table of Contents
Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status -United States, January 22 -October 3, 2020
Authors: Laura D. Zambrano, PhD, Sascha Ellington, PhD, Penelope Strid, MPH; Romeo R. Galang, MD; Titilope Oduyebo, MD; Van T. Tong, MPH1; Kate R. Woodworth, MD; John F. Nahabedian III, MS; Eduardo Azziz-Baumgartner, MD; Suzanne M. Gilboa, PhD; Dana Meaney-Delman, MD; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team
Publication Year: 2020
Journal: Centers for Disease Control: Morbidity and Mortality Weekly Report
Last Updated: 2020-11-10
Keywords: COVID-19, coronavirus, pregnancy, MMWR, pre-natal health
Abstract:
Summary
What is already known about this topic?
Limited information suggests that pregnant women with COVID-19 might be at increased risk for severe illness compared with nonpregnant women.
What is added by this report?
In an analysis of approximately 400,000 women aged 15–44 years with symptomatic COVID-19, intensive care unit admission, invasive ventilation, extracorporeal membrane oxygenation, and death were more likely in pregnant women than in nonpregnant women.
What are the implications for public health practice?
Pregnant women should be counseled about the risk for severe COVID-19–associated illness including death; measures to prevent infection with SARS-CoV-2 should be emphasized for pregnant women and their families. These findings can inform clinical practice, risk communication, and medical countermeasure allocation.
File Download:
Source: Link to Original Article.
